APP下载

维吾尔族和汉族前列腺癌患者内分泌治疗敏感时间的相关因素分析

2016-01-11孙涛,拜合提亚·阿扎提,哈木拉提·吐送等

新疆医科大学学报 2015年5期
关键词:前列腺癌

维吾尔族和汉族前列腺癌患者内分泌治疗敏感时间的相关因素分析

孙涛, 拜合提亚·阿扎提, 哈木拉提·吐送, 王文光, 木拉提·热夏提, 安恒庆, 王玉杰

(新疆医科大学第一附属医院泌尿中心, 乌鲁木齐830054)

摘要:目的探讨新疆地区维吾尔族与汉族前列腺癌患者内分泌治疗敏感时间及其影响内分泌治疗敏感时间的临床因素,为新疆地区前列腺癌患者的个体化治疗提供依据。方法将内分泌治疗至进展为去势抵抗性前列腺癌(CRPC)的时间定义为内分泌治疗敏感时间,回顾性分析111例单纯内分泌治疗的维吾尔族和汉族前列腺癌患者的临床资料,建立Cox回归模型,分析各临床因素和内分泌治疗敏感时间的相关关系。结果单因素分析显示,民族(P=0.508)、年龄(P=0.099)、单纯内分泌治疗方式(P=0.399)与内分泌治疗敏感时间无相关性。而初始PSA、临床分期、Gleason评分、PSA最低值、骨转移情况与内分泌治疗敏感时间存在显著相关关系(P<0.05)。多因素分析显示,仅临床分期(P=0.000)和最低PSA值(P=0.000)是前列腺癌患者内分泌治疗敏感时间的主要影响因素。临床分期越高,内分泌治疗后越早出现CRPC。内分泌治疗后PSA能降至0.2 ng/mL及以下的患者较晚发展为CRPC。结论新疆地区维吾尔族与汉族前列腺癌患者内分泌治疗敏感时间无差异,而临床分期与PSA最低值是前列腺癌内分泌治疗敏感时间的独立危险因素。

关键词:前列腺癌; 内分泌治疗; 民族

中图分类号:R737.25文献标识码:A

doi:10.3969/j.issn.1009-5551.2015.05.002

[收稿日期:2015-02-28]

基金项目:国家自然科学基金(81060210); 新疆维吾尔自治区自然科学基金重大项目(2013211A101); 新疆医科大学校级科研项目( 2012YFY28)

作者简介:夏韩(1987-),男,在读硕士,研究方向:泌尿系肿瘤。

Analysis of correlation factors on the sensitive time of endocrine therapy for

Uygur and Han patients with prostate cancer

SUN Tao, Baihetiya Azhati, Hamulati Tusong, WANG Wenguang, Mulati Rexiat, AN Hengqing, WANG Yujie

(DepartmentofUrology,TheFirstAffiliatedHospitalofXinjiangMedicalUniversity,

Urumqi830054,China)

Absract: ObjectiveTo explore the sensitive time of endocrine therapy between Xinjiang Uygur and Han patients with prostate cancer and the clinical factors that influence the sensitive time of endocrine therapy, so as to provide the basis of individualized treatment for patients with prostate cancer in the xinjiang region. MethodsWe defined the time from the beginning of endocrine therapy to developing as castration resistant prostate cancer (CRPC) as the sensitive time of endocrine therapy, in this study, we retrospectively analyzed the clinical data of 111 Uygur and Han patients with prostate cancer who had received endocrine therapy alone, set up the Cox regression model, and analyzed the relationship between various clinical factors and the sensitive time of endocrine therapy. ResultsUnivariate regression analysis revealed that the nation (P=0.508), age (P=0.099), method of endocrine therapy alone (P=0.399) had no correlation with the sensitive time of endocrine therapy, initial PSA value, clinical stage, Gleason score, nadir PSA value and bone metastases which existed significant correlation (P<0.05) with the sensitive time of endocrine therapy. Multivariate regression analysis revealed that only clinical stage (P=0.000) and nadir PSA value (P=0.000) were the main influencing factors for the sensitive time of endocrine therapy in patients with prostate cancer. Highor clinical stage lead to earlier CRPC appearance after endocrine theraphy. The patients with prostate cancer conld later grow into CRPC when their RSA value dropped to less than or equal to 0.2 ng/mL after endocrine therapy. ConclusionThere is no difference between Uygur and Han patients with prostate cancer in Xinjiang in regand to the sensitive time of evdocrine therapy, but clinical stage and nadir PSA value are independent risk factors for the sensitive time of endocrine therapy in patients with prostate cancer.

Key words:prostate cancer;endocrine therapy; ethnic groups

最新统计显示前列腺癌(prostate cancer, PCa)发病率位居于全球男性恶性肿瘤的第2位,死亡人数位居第8位[1]。临床上大部分的PCa患者确诊时已为晚期,通常采用雄激素剥夺治疗(androgen deprivation therapy,ADT),治疗初期有效,最终都会进展为去势抵抗性前列腺癌(castration resistant prostate cancer,CRPC),但其发生抵抗或临床进展的速度大相径庭。……

登录APP查看全文

猜你喜欢

前列腺癌
尿液检测可能会发现侵袭性前列腺癌
前列腺癌根治术和术后辅助治疗
前列腺癌的内分泌治疗
前列腺癌复发和转移的治疗
关注前列腺癌
认识前列腺癌
前列腺癌的治疗路径
前列腺癌的早期发现和早期治疗
MTA1和XIAP的表达与前列腺癌转移及预后的关系
前列腺癌,这些蛛丝马迹要重视